Health Disparities in Utilization, Quality, and Outcomes for Three Common Ocular Conditions (HealthDOC)

项目摘要/摘要： 多重 那 少数族裔 芯片 的 这个 明白了。 眼科 视网膜病变。 过去的研究提供了强有力的证据表明，在医疗保健领域存在差异，包括在眼科，以及 健康的社会决定因素(SDH)在解释民族和种族差异方面发挥着重要作用 接受医疗保健服务。随着《平价医疗法案》的通过，以及后来的医疗保险普及和 2015年《再授权法》一直强调医疗质量措施的实施 使用国家质量论坛(NQF)相关指标的医疗保险激励支付系统(MIPS)。 眼科疾病的质量衡量标准与医疗保健差距之间的关联性很差 事实上，几乎没有研究表明健康的社会决定因素是如何影响的 患有白内障、青光眼和糖尿病的种族/民族群体的护理实践和质量指标 三种常见眼科疾病在使用、质量和结果方面的建议健康差异 条件(HealthDOC)研究 用人 临床上 将通过以下方式解决临床质量措施和实践之间的普遍差距 严格的健康服务和结果研究设计，评估眼科NQF，以及 使用S之夜研究合作中心的有意义的措施(来源：研究健康) 差距。源链接并从电子健康记录中提取跨医疗保健系统的数据以捕获 视觉变化，临床细节(通常无法获得，但通过临床试验)，以及健康差异，这是 是健康人群2030年目测目标的理想选择。Source克服了以下方面的主要数据障碍 眼科健康差异使用视觉结果细节来衡量治疗、质量和 结果，加上关于种族和族裔的关键信息、性别的生物变量、SDH测量、 药物，血红蛋白A1c，疾病控制中心国家死亡指数数据和其他。本研究 将检查三种主要眼病(白内障、青光眼、糖尿病眼病)，并量化 SDH对已建立的和同行评审的NQF眼质量指标的实现，以及临床意义 青光眼和慢性青光眼慢性疾病的视力结局、非眼部发病率和死亡率的措施 糖尿病视网膜病变。我们关注的眼部状况是导致视力不可逆的最常见原因 美国的损伤和失明，并实现了国家眼科研究所和健康人的目标 2030年。这 关于眼部护理的差异)， 利用 国家 差距 全国 创新，2个利益相关者驱动 3)使用公认质量指标(NQF)与医疗保健管理保持一致，以及4 来自27个眼科项目站点的电子健康记录的现有数据，涵盖多个 和区域，侧重于旨在未来减少健康的干预措施的质量改进倡议 跨来源站点和国外。该项目与NIH、NEI和NIH的任务非常一致 医学科学院(NAM)关于减少健康差距和预防视力丧失的研究。 研究内容为：1))(美国眼科学会，工作组 )

Project Summary/Abstract: Multiple that minority CHIP of The understood. ophthalmology retinopathy. past studies provide strong evidence that disparities exist in healthcare, i ncluding in ophthalmology, and social determinant of health (SDH) play an important role for explaining differences in ethnic and racial receipt of healthcare. With the passage of the Affordable Care Act and later the Medicare Access and Reauthorization Act of 2015, there has been emphasis on medical quality measures with implementation the Medicare Incentive Payment System (MIPS) with the use of National Quality Forum (NQF) related metrics. association between quality measures for ophthalmic conditions and healthcare disparities is poorly In fact, there has been little research to inform how the social determinants of health impact care practices and quality metrics by racial/ethnic groups with cataract, glaucoma, and diabetic The proposedHealth Disparities in Utilization, Quality, and Outcomes for Three Common Ocular Conditions (HealthDOC) study employing clinically will address prevailing gaps between clinical quality measures and practice by a rigorous health services and outcomes research study design that evaluates ophthalmic NQF, and meaningful measures using the S ight OU tcomes R esearch C ollaborativ E ( SOURCE to study health) disparities. SOURCE links and extracts data across healthcare systems from electronic health records to capture visual changes, clinical details (typically not available but through clinical trials), and health disparities, which is ideal for responding to Healthy People 2030 ocular goals. SOURCE overcomes major data barriers in ophthalmology health disparities work with visual outcome details for measuring treatment, quality, and outcomes, joined with key information on race and ethnicity, the biological variable of gender, SDH measures, medications, hemoglobin A1c, Centers for Disease Control National Death Index Data and others. This study will examine three major eye diseases (cataract, glaucoma, diabetic eye disease) and quantify the impact of SDH on achievement of established and peer reviewed NQF ocular quality metrics, and clinically meaningful measures on visual outcomes, and non-ocular morbidity and mortality for the chronic diseases of glaucoma and diabetic retinopathy. The ocular conditions we focus on are the most common causes of irreversible visual impairment and blindness in the U.S. and fulfills the target goals for National Eye Institute and Healthy People 2030. This on Eye Care Disparities), leveraging states disparities National innovative, 2 stakeholder-driven 3 ) aligned with healthcare management using accepted quality metrics (NQF), and 4 existing data from electronic health records of 27 ophthalmology program sites covering multiple and regions, focused on quality improvement initiatives aimed at future interventions to reduce health across SOURCE sites and abroad. This project aligns well with the missions of the NIH, NEI, and Academy of Medicine (NAM) on reducing health disparities and the prevention of vision loss. study is: 1) ) (American Academy of Ophthalmology, Task Force )